These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24571424)

  • 1. Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II-III rectal cancer: A population-based study.
    Ke TW; Liao YM; Chiang HC; Chang SC; Wang PH; Chen YY; Chen WT; Chien CR
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e234-40. PubMed ID: 24571424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.
    Li CC; Liang JA; Chen WT; Chien CR
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e197-e203. PubMed ID: 31250970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
    Li CC; Liang JA; Chung CY; Chen WT; Chien CR
    Anticancer Res; 2019 Mar; 39(3):1479-1484. PubMed ID: 30842185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
    Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the interval between neoadjuvant concurrent chemoradiotherapy and esophagectomy in the modern era: a population-based propensity-score-matched retrospective cohort study in Asia.
    Kuo YH; Chien YW; Chen PR; Feng CL; Li CC; Chien CR
    World J Surg Oncol; 2019 Dec; 17(1):222. PubMed ID: 31856840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
    Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
    Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
    Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Mitomycin-C in neoadjuvant concurrent chemoradiotherapy for rectal cancer.
    Wang LW; Liu YS; Jiang JK
    J Chin Med Assoc; 2022 Dec; 85(12):1120-1125. PubMed ID: 36194168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study.
    Ke TW; Chang SC; Liao YM; Lin CH; Chen WT; Liang JA; Li CC; Chien CR
    Anticancer Res; 2023 Dec; 43(12):5713-5722. PubMed ID: 38030192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional Probability of Survival After Neoadjuvant Chemoradiation and Proctectomy for Rectal Cancer: What Matters and When.
    Karagkounis G; Liska D; Kalady MF
    Dis Colon Rectum; 2019 Jan; 62(1):33-39. PubMed ID: 30451761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy after neoadjuvant chemoradiation and proctectomy improves survival irrespective of pathologic response in rectal adenocarcinoma: a population-based cohort study.
    Naffouje SA; Liu YJ; Kamarajah SK; Salti GI; Dahdaleh F
    Int J Colorectal Dis; 2022 Oct; 37(10):2137-2148. PubMed ID: 36048196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of neoadjuvant concurrent chemoradiotherapy versus esophagectomy for locally advanced esophageal squamous cell carcinoma: A population-based matched case-control study.
    Lin CY; Fang HY; Feng CL; Li CC; Chien CR
    Thorac Cancer; 2016 Apr; 7(3):288-95. PubMed ID: 27148413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Is the Utility of Restaging Imaging for Patients With Clinical Stage II/III Rectal Cancer After Completion of Neoadjuvant Chemoradiation and Prior to Proctectomy?
    Hendrick LE; Buckner JD; Guerrero WM; Shibata D; Hinkle NM; Monroe JJ; Glazer ES; Deneve JL; Dickson PV
    Am Surg; 2021 Feb; 87(2):242-247. PubMed ID: 32927959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort Study.
    Ke TW; Chang SC; Chen HC; Wang HM; Chen WT; Chen YC; Hsieh MH; Tsai YY; Huang CW; Liao YM; Lin CH; Huang CL; Chen LC; Chien CR
    Anticancer Res; 2023 Apr; 43(4):1843-1851. PubMed ID: 36974811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Kuan FC; Lai CH; Ku HY; Wu CF; Hsieh MC; Liu TW; Yeh CY; Lee KD
    Int J Cancer; 2017 Apr; 140(7):1662-1669. PubMed ID: 27935051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
    Charlton ME; Stitzenberg KB; Lin C; Schlichting JA; Halfdanarson TR; Juarez GY; Pendergast JF; Chrischilles EA; Wallace RB
    J Oncol Pract; 2015 Jul; 11(4):e476-86. PubMed ID: 26080831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.